(19)
(11) EP 3 348 273 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.09.2019 Bulletin 2019/38

(45) Mention of the grant of the patent:
31.07.2019 Bulletin 2019/31

(21) Application number: 18157960.8

(22) Date of filing: 15.04.2015
(51) International Patent Classification (IPC): 
A61K 38/01(2006.01)
A61P 13/00(2006.01)
A61K 47/36(2006.01)

(54)

COMPOSITIONS BASED ON XYLOGLUCAN AND PROTEINS FOR THE TREATMENT OF INTESTINAL DISORDERS

ZUSAMMENSETZUNGEN BASIEREND AUF XYLOGLUCAN UND PROTEINEN ZUR BEHANDLUNG VON DARMERKRANKUNGEN

COMPOSITIONS À BASE DE PROTÉINES ET DE XYLOGLUCANE POUR LE TRAITEMENT DE TROUBLES INTESTINAUX


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 15.04.2014 IT MI20140705

(43) Date of publication of application:
18.07.2018 Bulletin 2018/29

(62) Application number of the earlier application in accordance with Art. 76 EPC:
15719637.9 / 3131568

(73) Proprietor: Devintec, Sagl
6900 Lugano (CH)

(72) Inventors:
  • ALONSO COHEN, Miguel Angel
    08034 BARCELONA (ES)
  • DI SCHIENA, Michele Giuseppe
    20087 ROBECCO SUL NAVIGLIO (MI) (IT)
  • DI FULVIO, Marco
    6915 LUGANO (CH)

(74) Representative: Bianchetti Bracco Minoja S.r.l. 
Via Plinio, 63
20129 Milano
20129 Milano (IT)


(56) References cited: : 
EP-A1- 2 526 939
WO-A1-2014/020408
WO-A1-2009/008005
   
  • W. NIE ET AL: "Tamarind Seed Xyloglucans Promote Proliferation and Migration of Human Skin Cells through Internalization via Stimulation of Proproliferative Signal Transduction Pathways", DERMATOLOGY RESEARCH AND PRACTICE, vol. 35, no. 5-6, 1 January 2013 (2013-01-01), pages 455-14, XP055151822, ISSN: 1687-6105, DOI: 10.1016/0278-6915(96)87356-X
  • HAVINGA R M ET AL: "Tamarindus indica L. (Fabaceae): Patterns of use in traditional African medicine", JOURNAL OF ETHNOPHARMACOLOGY, ELSEVIER IRELAND LTD, IE, vol. 127, no. 3, 17 February 2010 (2010-02-17), pages 573-588, XP026884170, ISSN: 0378-8741, DOI: 10.1016/J.JEP.2009.11.028 [retrieved on 2009-12-04]
  • HUANG YA-LING ET AL: "Water-insoluble fiber-rich fraction from pineapple peel improves intestinal function in hamsters: evidence from cecal and fecal indicators", NUTRITION RESEARCH, vol. 34, no. 4, 12 March 2014 (2014-03-12) , pages 346-354, XP028643193, ISSN: 0271-5317, DOI: 10.1016/J.NUTRES.2014.03.001
  • Kiyoshi Ebihara ET AL: "COMPARATIVE EFFECT OF WATER-SOLUBLE AND -INSOLUBLE DIETARY FIBER ON BOWEL FUNCTION IN RATS FED A LIQUID ELEMENTAL DIET", ELSEVIER Nutrition Research Copyright, 1 January 1998 (1998-01-01), page 883491, XP055095821, Retrieved from the Internet: URL:http://www.sciencedirect.com/science/a rticle/pii/S0271531798000736/pdf?md5=ce093 6aae6bfe88945d349ea6df03a1c&pid=1-s2.0-S02 71531798000736-main.pdf [retrieved on 2014-01-10]
  • Lionel Bueno: "XYLOGLUCAN: A NEW AGENT TO PROTECT THE INTESTINAL MUCOSA AND TO PREVENT BACTERIALLY- MEDIATED ALTERATION OF TIGHT JUNCTION PERMEABILITY.", UEG Week Vienna 2014 , 22 October 2014 (2014-10-22), XP002732270, Retrieved from the Internet: URL:http://uegw.congress-online.com/guest/ AbstractView?ABSID=8331 [retrieved on 2014-11-10]
  • NDIAYE FATOU ET AL: "Anti-oxidant, anti-inflammatory and immunomodulating properties of an enzymatic protein hydrolysate from yellow field pea seeds.", February 2012 (2012-02), EUROPEAN JOURNAL OF NUTRITION FEB 2012, VOL. 51, NR. 1, PAGE(S) 29 - 37, XP035006350, ISSN: 1436-6215 * abstract *
 
Remarks:
The file contains technical information submitted after the application was filed and not included in this specification
 
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).